NOTCH1 and neoplasm: A small-molecule drug ABT-737 and tumor-suppressive microRNA (miRNA) miR-34a, which are promising candidates for TNBC therapy, were encapsulated in poly(lactic-co-glycolic acid) nanoparticles (NP) and functionalized with Notch-1.